SEC Form 4 · accession 0001104659-16-129268
Aralez Pharmaceuticals Inc. · ARLZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jennifer Lou Armstrong
Officer — EVP HR and Administration
Period of report
Jun 22, 2016
Accepted (ET)
Jun 24, 2016 · 4:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001660719
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares, without par value | Jun 22, 2016 | F | 6,850 | $3.34 | D | 111,729 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This represents shares withheld by the Issuer for payment of withholding tax liability incurred upon the vesting of 21,749 restricted stock units, 5,463 of which were previously granted on June 22, 2015 and 16,286 of which were previously granted on February 12, 2016, all of which vested on June 22, 2016.